Physical Activity Behavior Intervention for Arthrosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Arthrosis+1 More
Physical Activity Behavior Intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will use mobile technology to improve physical activity for Veterans who have had total knee surgery, with the goal of helping them recover better.

Eligible Conditions
  • Arthrosis
  • Total Knee Arthroplasty (TKA)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Arthrosis

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Change from pre-surgery to end of intervention (14 weeks), persisting at 24 weeks after intervention

Week 14
Free-living daily step count
Week 24
30-Second Chair-Stand Test
Six-Minute Walk Test
Timed Up-and-Go Test
Veterans RAND 12-Item Health Survey
Western Ontario and McMaster Universities Osteoarthritis Index

Trial Safety

Safety Progress

1 of 3

Other trials for Arthrosis

Trial Design

2 Treatment Groups

Attention Control
1 of 2
Physical Activity Behavior Intervention
1 of 2
Active Control
Experimental Treatment

114 Total Participants · 2 Treatment Groups

Primary Treatment: Physical Activity Behavior Intervention · No Placebo Group · N/A

Physical Activity Behavior Intervention
Behavioral
Experimental Group · 1 Intervention: Physical Activity Behavior Intervention · Intervention Types: Behavioral
Attention Control
Other
ActiveComparator Group · 1 Intervention: Attention Control · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change from pre-surgery to end of intervention (14 weeks), persisting at 24 weeks after intervention

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,473 Previous Clinical Trials
2,741,642 Total Patients Enrolled
Cory L. Christiansen, PhDPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
3 Previous Clinical Trials
163 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 8th, 2021

Last Reviewed: October 20th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.